Bromodomain 4 inhibition leads to <i>MYCN</i> downregulation in Wilms’ tumor cells
Andrew D. Woods(Children's Cancer Therapy Development Institute), Charles Keller(Children's Cancer Therapy Development Institute)
Cited by 0
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Alveolar rhabdomyosarcomas in conditional <i>Pax3:Fkhr</i> mice: cooperativity of Ink4a/ARF and Trp53 loss of function
|Genes & Development|2004|299
Evidence for an Unanticipated Relationship between Undifferentiated Pleomorphic Sarcoma and Embryonal Rhabdomyosarcoma
|Cancer Cell|2011|190
Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|136
Lineage of origin in rhabdomyosarcoma informs pharmacological response
|Genes & Development|2014|104